organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

Crystal structure of 2-(4-methyl­piperazin-1-yl)quinoline-3-carbaldehyde

aDepartment of Chemistry, University College of Science, Tumkur University, Tumkur 572 103, India, bInstitution of Excellence, University of Mysore, Mysuru-6, India, and cDepartment of Physics, University of Mysore, Mysuru-6, India
*Correspondence e-mail: drsreenivasa@yahoo.co.in

Edited by M. Gdaniec, Adam Mickiewicz University, Poland (Received 16 October 2015; accepted 26 October 2015; online 31 October 2015)

In the title compound, C15H17N3O, the aldehyde group is twisted relative to the quinoline group by17.6 (2)° due to the presence of a bulky piperazinyl group in the ortho position. The piperazine N atom attached to the aromatic ring is sp3-hybridized and the dihedral angle between the mean planes through the the six piperazine ring atoms and through the quinoline ring system is 40.59 (7)°. Both piperazine substituents are in equatorial positions.

1. Related literature

For biological activity of quinoline derivatives, see: Nasveld et al. (2005[Nasveld, P. & Kitchener, S. (2005). Trans. R. Soc. Trop. Med. Hyg. 99, 2-5.]); Eswaran et al. (2009[Eswaran, S., Adhikari, A. V. & Shetty, N. S. (2009). Eur. J. Med. Chem. 44, 4637-4647.]); Leatham et al. (1983[Leatham, P. A., Bird, H. A., Wright, V., Seymour, D. & Gordon, A. (1983). Eur. J. Rheumatol. Inflamm. 6, 209-211.]); Muruganantham et al. (2004[Muruganantham, N., Sivakumar, R., Anbalagan, N., Gunasekaran, V. & Leonard, J. T. (2004). Biol. Pharm. Bull. 27, 1683-1687.]); Maguire et al. (1994[Maguire, M. P., Sheets, K. R., McVety, K., Spada, A. P. & Zilberstein, A. (1994). J. Med. Chem. 37, 2129-2137.]); Wilson et al. (1992[Wilson, W. D., Zhao, M., Patterson, S. E., Wydra, R. L., Janda, L. & Strekowski, L. (1992). J. Med. Chem. Res. 2, 102-110.]); Strekowski et al. (1991[Strekowski, L., Mokrosz, J. L., Honkan, V. A., Czarny, A., Cegla, M. T., Wydra, R. L., Patterson, S. E. & Schinazi, R. F. (1991). J. Med. Chem. 34, 1739-1746.]). For photonic and electronic properties of poly-substituted quinolines, see: Gyoten et al. (2003[Gyoten, M., Nagaya, H., Fukuda, S., Ashida, Y. & Kawano, Y. (2003). Chem. Pharm. Bull. 51, 122-133.]).

[Scheme 1]

2. Experimental

2.1. Crystal data

  • C15H17N3O

  • Mr = 255.32

  • Monoclinic, P 21 /n

  • a = 12.3282 (4) Å

  • b = 5.8935 (2) Å

  • c = 18.9202 (7) Å

  • β = 103.591 (2)°

  • V = 1336.18 (8) Å3

  • Z = 4

  • Cu Kα radiation

  • μ = 0.65 mm−1

  • T = 296 K

  • 0.28 × 0.26 × 0.24 mm

2.2. Data collection

  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2009[Bruker (2009). APEX2, SADABS, SAINT-Plus and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.838, Tmax = 0.859

  • 9762 measured reflections

  • 2181 independent reflections

  • 1859 reflections with I > 2σ(I)

  • Rint = 0.048

2.3. Refinement

  • R[F2 > 2σ(F2)] = 0.054

  • wR(F2) = 0.162

  • S = 1.06

  • 2181 reflections

  • 173 parameters

  • H-atom parameters constrained

  • Δρmax = 0.22 e Å−3

  • Δρmin = −0.24 e Å−3

Data collection: APEX2 (Bruker, 2009[Bruker (2009). APEX2, SADABS, SAINT-Plus and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: APEX2 and SAINT-Plus (Bruker, 2009[Bruker (2009). APEX2, SADABS, SAINT-Plus and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT-Plus and XPREP (Bruker, 2009[Bruker (2009). APEX2, SADABS, SAINT-Plus and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: Mercury (Macrae et al., 2008[Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.]); software used to prepare material for publication: SHELXL97.

Supporting information


Introduction top

Quinoline and its derivatives have been well known in pharmaceutical chemistry because of their wide spectrum of biological activities and their presence in naturally occurring compounds. They have been shown to possess anti­malarial (Nasveld et al., 2005), anti­biotic (Eswaran et al., 2009), anti­cancer (Denny et al., 1983), anti-inflammatory (Muruganantham et al., 2004), anti­hypertensive (Maguire et al., 1994), tyrokinase PDGF-RTK inhibition (Wilson et al., 1992) and anti-HIV properties (Strekowski et al., 1991). In addition, polysubstituted quinoline can achieve hierchical self-assembly into variety of meso and nano structures with enhanced photonic and electronic properties (Gyoten et al., 2003). In this view the title compound was synthesized to study its crystal structure.

Experimental top

Synthesis and crystallization top

2-Chloro­quinoline-3-carbaldehyde (0.42 g, 0.00351 mmol), N-methyl piperazine (0.14 g, 0.00351 mmol) and anhydrous K2CO3 (1.0 g, 0.002920 mmol) were refluxed for 24 hrs in DMF. The progress of the reaction was monitored by thin layer chromatography. After the completion of the reaction, the reaction mixture was poured into water and extracted to ethyl acetate. The organic layer was washed with water, dried and concentrated under vacuum using rotary evaporator. Single crystals of the title compound were obtained by slow evaporation of the ethyl acetate solution at room temperature (27oC).

Refinement top

Crystal data, data collection and structure refinement details are summarized in Table 1. All H atoms were positioned with idealized geometry using a riding model with C—H = 0.93-0.97 Å. All H atoms were refined with isotropic displacement parameters (set to 1.2 times of the Ueq of the parent C atom).

Results and discussion top

The crystal packing of the compound does not feature any specific strong or weak inter­molecular inter­actions.

Related literature top

For biological activity of quinoline derivatives, see: Nasveld et al. (2005); Eswaran et al. (2009); Leatham et al. (1983); Muruganantham et al. (2004); Maguire et al. (1994); Wilson et al. (1992); Strekowski et al. (1991). For photonic and electronic properties of poly-substituted quinolines, see: Gyoten et al. (2003).

Structure description top

Quinoline and its derivatives have been well known in pharmaceutical chemistry because of their wide spectrum of biological activities and their presence in naturally occurring compounds. They have been shown to possess anti­malarial (Nasveld et al., 2005), anti­biotic (Eswaran et al., 2009), anti­cancer (Denny et al., 1983), anti-inflammatory (Muruganantham et al., 2004), anti­hypertensive (Maguire et al., 1994), tyrokinase PDGF-RTK inhibition (Wilson et al., 1992) and anti-HIV properties (Strekowski et al., 1991). In addition, polysubstituted quinoline can achieve hierchical self-assembly into variety of meso and nano structures with enhanced photonic and electronic properties (Gyoten et al., 2003). In this view the title compound was synthesized to study its crystal structure.

The crystal packing of the compound does not feature any specific strong or weak inter­molecular inter­actions.

For biological activity of quinoline derivatives, see: Nasveld et al. (2005); Eswaran et al. (2009); Leatham et al. (1983); Muruganantham et al. (2004); Maguire et al. (1994); Wilson et al. (1992); Strekowski et al. (1991). For photonic and electronic properties of poly-substituted quinolines, see: Gyoten et al. (2003).

Synthesis and crystallization top

2-Chloro­quinoline-3-carbaldehyde (0.42 g, 0.00351 mmol), N-methyl piperazine (0.14 g, 0.00351 mmol) and anhydrous K2CO3 (1.0 g, 0.002920 mmol) were refluxed for 24 hrs in DMF. The progress of the reaction was monitored by thin layer chromatography. After the completion of the reaction, the reaction mixture was poured into water and extracted to ethyl acetate. The organic layer was washed with water, dried and concentrated under vacuum using rotary evaporator. Single crystals of the title compound were obtained by slow evaporation of the ethyl acetate solution at room temperature (27oC).

Refinement details top

Crystal data, data collection and structure refinement details are summarized in Table 1. All H atoms were positioned with idealized geometry using a riding model with C—H = 0.93-0.97 Å. All H atoms were refined with isotropic displacement parameters (set to 1.2 times of the Ueq of the parent C atom).

Computing details top

Data collection: APEX2 (Bruker, 2009); cell refinement: APEX2 and SAINT-Plus (Bruker, 2009); data reduction: SAINT-Plus and XPREP (Bruker, 2009); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: Mercury (Macrae et al., 2008); software used to prepare material for publication: SHELXL97 (Sheldrick, 2008).

Figures top
[Figure 1] Fig. 1. Molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level.
2-(4-Methylpiperazin-1-yl)quinoline-3-carbaldehyde top
Crystal data top
C15H17N3OPrism
Mr = 255.32Dx = 1.269 Mg m3
Monoclinic, P21/nMelting point: 384 K
Hall symbol: -P 2ynCu Kα radiation, λ = 1.54178 Å
a = 12.3282 (4) ÅCell parameters from 143 reflections
b = 5.8935 (2) Åθ = 3.9–64.5°
c = 18.9202 (7) ŵ = 0.65 mm1
β = 103.591 (2)°T = 296 K
V = 1336.18 (8) Å3Prism, colourless
Z = 40.28 × 0.26 × 0.24 mm
F(000) = 544
Data collection top
Bruker APEXII CCD
diffractometer
2181 independent reflections
Radiation source: fine-focus sealed tube1859 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.048
phi and φ scansθmax = 64.5°, θmin = 3.9°
Absorption correction: multi-scan
(SADABS; Bruker, 2009)
h = 1414
Tmin = 0.838, Tmax = 0.859k = 66
9762 measured reflectionsl = 2121
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.054Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.162H-atom parameters constrained
S = 1.06 w = 1/[σ2(Fo2) + (0.1151P)2 + 0.0654P]
where P = (Fo2 + 2Fc2)/3
2181 reflections(Δ/σ)max < 0.001
173 parametersΔρmax = 0.22 e Å3
0 restraintsΔρmin = 0.24 e Å3
Crystal data top
C15H17N3OV = 1336.18 (8) Å3
Mr = 255.32Z = 4
Monoclinic, P21/nCu Kα radiation
a = 12.3282 (4) ŵ = 0.65 mm1
b = 5.8935 (2) ÅT = 296 K
c = 18.9202 (7) Å0.28 × 0.26 × 0.24 mm
β = 103.591 (2)°
Data collection top
Bruker APEXII CCD
diffractometer
2181 independent reflections
Absorption correction: multi-scan
(SADABS; Bruker, 2009)
1859 reflections with I > 2σ(I)
Tmin = 0.838, Tmax = 0.859Rint = 0.048
9762 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0540 restraints
wR(F2) = 0.162H-atom parameters constrained
S = 1.06Δρmax = 0.22 e Å3
2181 reflectionsΔρmin = 0.24 e Å3
173 parameters
Special details top

Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
N10.44347 (10)0.7887 (2)0.60405 (6)0.0446 (4)
N20.31637 (10)0.4894 (2)0.58318 (6)0.0443 (4)
N30.15374 (11)0.2821 (2)0.46867 (7)0.0492 (4)
O10.33529 (13)0.4038 (3)0.79890 (7)0.0800 (5)
C10.38623 (12)0.6362 (3)0.63074 (7)0.0415 (4)
C20.39605 (12)0.6082 (3)0.70773 (8)0.0435 (4)
C30.46317 (13)0.7537 (3)0.75426 (8)0.0456 (4)
H30.46900.74100.80400.055*
C40.52382 (12)0.9229 (3)0.72789 (8)0.0429 (4)
C50.59503 (14)1.0786 (3)0.77313 (9)0.0517 (5)
H50.60351.07180.82320.062*
C60.65119 (15)1.2380 (3)0.74416 (10)0.0571 (5)
H60.69801.33970.77440.068*
C70.63874 (16)1.2497 (3)0.66853 (10)0.0580 (5)
H70.67681.36060.64900.070*
C80.57153 (14)1.1003 (3)0.62334 (9)0.0516 (5)
H80.56481.10940.57340.062*
C90.51232 (12)0.9326 (3)0.65156 (8)0.0430 (4)
C100.19665 (13)0.5037 (3)0.58101 (8)0.0477 (4)
H10A0.16590.64130.55600.057*
H10B0.18610.51000.63020.057*
C110.13648 (13)0.3007 (3)0.54226 (9)0.0517 (5)
H11A0.16350.16420.56940.062*
H11B0.05730.31420.53990.062*
C120.27299 (14)0.2697 (3)0.47221 (9)0.0522 (5)
H12A0.28460.25820.42340.063*
H12B0.30380.13470.49880.063*
C130.33266 (14)0.4768 (3)0.50926 (8)0.0516 (5)
H13A0.41170.46700.51060.062*
H13B0.30310.61230.48240.062*
C140.09682 (18)0.0831 (4)0.43236 (9)0.0660 (6)
H14A0.11060.07080.38460.099*
H14B0.01810.09730.42850.099*
H14C0.12420.05010.46000.099*
C150.34545 (14)0.4132 (3)0.73732 (9)0.0561 (5)
H150.32010.29130.70670.067*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
N10.0470 (7)0.0482 (8)0.0386 (7)0.0039 (6)0.0102 (6)0.0002 (5)
N20.0423 (7)0.0538 (9)0.0381 (7)0.0054 (6)0.0119 (5)0.0038 (6)
N30.0541 (8)0.0505 (9)0.0400 (7)0.0114 (6)0.0047 (6)0.0021 (6)
O10.0885 (10)0.1024 (13)0.0487 (8)0.0299 (8)0.0151 (7)0.0178 (7)
C10.0400 (8)0.0462 (9)0.0389 (8)0.0020 (6)0.0102 (6)0.0015 (6)
C20.0408 (8)0.0503 (10)0.0392 (8)0.0025 (6)0.0088 (6)0.0038 (7)
C30.0456 (9)0.0556 (10)0.0348 (8)0.0055 (7)0.0076 (6)0.0042 (7)
C40.0402 (8)0.0467 (9)0.0407 (8)0.0049 (6)0.0077 (6)0.0001 (6)
C50.0529 (10)0.0568 (11)0.0431 (8)0.0002 (8)0.0064 (7)0.0061 (7)
C60.0583 (10)0.0557 (11)0.0549 (10)0.0102 (8)0.0086 (8)0.0100 (8)
C70.0640 (11)0.0530 (11)0.0576 (10)0.0139 (8)0.0155 (8)0.0007 (8)
C80.0574 (10)0.0544 (11)0.0439 (8)0.0055 (8)0.0142 (7)0.0014 (7)
C90.0427 (8)0.0458 (10)0.0402 (8)0.0020 (6)0.0090 (6)0.0002 (6)
C100.0450 (9)0.0568 (11)0.0420 (8)0.0011 (7)0.0117 (6)0.0002 (7)
C110.0481 (9)0.0603 (11)0.0465 (9)0.0097 (7)0.0108 (7)0.0025 (7)
C120.0614 (10)0.0561 (11)0.0402 (8)0.0041 (7)0.0143 (7)0.0042 (7)
C130.0513 (9)0.0644 (11)0.0424 (8)0.0112 (8)0.0180 (7)0.0056 (7)
C140.0820 (13)0.0605 (12)0.0491 (10)0.0239 (9)0.0026 (9)0.0008 (8)
C150.0567 (10)0.0634 (12)0.0449 (9)0.0096 (8)0.0050 (7)0.0107 (8)
Geometric parameters (Å, º) top
N1—C11.315 (2)C6—H60.9300
N1—C91.375 (2)C7—C81.364 (3)
N2—C11.391 (2)C7—H70.9300
N2—C131.4607 (18)C8—C91.406 (2)
N2—C101.4693 (19)C8—H80.9300
N3—C141.454 (2)C10—C111.505 (2)
N3—C121.458 (2)C10—H10A0.9700
N3—C111.461 (2)C10—H10B0.9700
O1—C151.202 (2)C11—H11A0.9700
C1—C21.442 (2)C11—H11B0.9700
C2—C31.361 (2)C12—C131.510 (2)
C2—C151.479 (2)C12—H12A0.9700
C3—C41.406 (2)C12—H12B0.9700
C3—H30.9300C13—H13A0.9700
C4—C51.411 (2)C13—H13B0.9700
C4—C91.419 (2)C14—H14A0.9600
C5—C61.357 (3)C14—H14B0.9600
C5—H50.9300C14—H14C0.9600
C6—C71.404 (3)C15—H150.9300
C1—N1—C9118.40 (12)N2—C10—C11110.18 (13)
C1—N2—C13116.58 (12)N2—C10—H10A109.6
C1—N2—C10116.60 (12)C11—C10—H10A109.6
C13—N2—C10109.84 (11)N2—C10—H10B109.6
C14—N3—C12110.53 (15)C11—C10—H10B109.6
C14—N3—C11110.40 (13)H10A—C10—H10B108.1
C12—N3—C11109.34 (12)N3—C11—C10111.00 (13)
N1—C1—N2118.89 (12)N3—C11—H11A109.4
N1—C1—C2122.74 (14)C10—C11—H11A109.4
N2—C1—C2118.32 (13)N3—C11—H11B109.4
C3—C2—C1118.36 (14)C10—C11—H11B109.4
C3—C2—C15119.41 (14)H11A—C11—H11B108.0
C1—C2—C15121.90 (15)N3—C12—C13110.89 (14)
C2—C3—C4120.69 (14)N3—C12—H12A109.5
C2—C3—H3119.7C13—C12—H12A109.5
C4—C3—H3119.7N3—C12—H12B109.5
C3—C4—C5123.55 (14)C13—C12—H12B109.5
C3—C4—C9117.08 (14)H12A—C12—H12B108.0
C5—C4—C9119.36 (15)N2—C13—C12108.90 (13)
C6—C5—C4120.59 (15)N2—C13—H13A109.9
C6—C5—H5119.7C12—C13—H13A109.9
C4—C5—H5119.7N2—C13—H13B109.9
C5—C6—C7120.09 (16)C12—C13—H13B109.9
C5—C6—H6120.0H13A—C13—H13B108.3
C7—C6—H6120.0N3—C14—H14A109.5
C8—C7—C6120.80 (16)N3—C14—H14B109.5
C8—C7—H7119.6H14A—C14—H14B109.5
C6—C7—H7119.6N3—C14—H14C109.5
C7—C8—C9120.59 (15)H14A—C14—H14C109.5
C7—C8—H8119.7H14B—C14—H14C109.5
C9—C8—H8119.7O1—C15—C2123.51 (18)
N1—C9—C8118.78 (13)O1—C15—H15118.2
N1—C9—C4122.64 (14)C2—C15—H15118.2
C8—C9—C4118.56 (15)

Experimental details

Crystal data
Chemical formulaC15H17N3O
Mr255.32
Crystal system, space groupMonoclinic, P21/n
Temperature (K)296
a, b, c (Å)12.3282 (4), 5.8935 (2), 18.9202 (7)
β (°) 103.591 (2)
V3)1336.18 (8)
Z4
Radiation typeCu Kα
µ (mm1)0.65
Crystal size (mm)0.28 × 0.26 × 0.24
Data collection
DiffractometerBruker APEXII CCD
Absorption correctionMulti-scan
(SADABS; Bruker, 2009)
Tmin, Tmax0.838, 0.859
No. of measured, independent and
observed [I > 2σ(I)] reflections
9762, 2181, 1859
Rint0.048
(sin θ/λ)max1)0.585
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.054, 0.162, 1.06
No. of reflections2181
No. of parameters173
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å3)0.22, 0.24

Computer programs: APEX2 (Bruker, 2009), APEX2 and SAINT-Plus (Bruker, 2009), SAINT-Plus and XPREP (Bruker, 2009), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Mercury (Macrae et al., 2008).

 

Acknowledgements

The authors are thankful to the Institution of Excellence, Vijnana Bhavana, University of Mysore, Mysuru, for providing the single-crystal X-ray diffraction facility. RND, SS, PAS and DBAK are thankful to Tumkur University for providing laboratory facilities to carry out this work.

References

First citationBruker (2009). APEX2, SADABS, SAINT-Plus and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.  Google Scholar
First citationEswaran, S., Adhikari, A. V. & Shetty, N. S. (2009). Eur. J. Med. Chem. 44, 4637–4647.  Web of Science CrossRef PubMed CAS Google Scholar
First citationGyoten, M., Nagaya, H., Fukuda, S., Ashida, Y. & Kawano, Y. (2003). Chem. Pharm. Bull. 51, 122–133.  CrossRef PubMed CAS Google Scholar
First citationLeatham, P. A., Bird, H. A., Wright, V., Seymour, D. & Gordon, A. (1983). Eur. J. Rheumatol. Inflamm. 6, 209–211.  CAS PubMed Google Scholar
First citationMacrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470.  Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
First citationMaguire, M. P., Sheets, K. R., McVety, K., Spada, A. P. & Zilberstein, A. (1994). J. Med. Chem. 37, 2129–2137.  CrossRef CAS PubMed Web of Science Google Scholar
First citationMuruganantham, N., Sivakumar, R., Anbalagan, N., Gunasekaran, V. & Leonard, J. T. (2004). Biol. Pharm. Bull. 27, 1683–1687.  CrossRef PubMed CAS Google Scholar
First citationNasveld, P. & Kitchener, S. (2005). Trans. R. Soc. Trop. Med. Hyg. 99, 2–5.  Web of Science CrossRef PubMed Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationStrekowski, L., Mokrosz, J. L., Honkan, V. A., Czarny, A., Cegla, M. T., Wydra, R. L., Patterson, S. E. & Schinazi, R. F. (1991). J. Med. Chem. 34, 1739–1746.  CrossRef CAS PubMed Google Scholar
First citationWilson, W. D., Zhao, M., Patterson, S. E., Wydra, R. L., Janda, L. & Strekowski, L. (1992). J. Med. Chem. Res. 2, 102–110.  CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds